<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>AAVS_ 507 Nexus</title>
		<link href="http://nexusacademicpublishers.com/uploads/cssfiles/AAVS_ 507 Nexus.css" rel="stylesheet" type="text/css" />
	</head>
    <style> 
.pt{
	background-color:#BDF;
	border-top-style:solid;
	
	border-top-color:#d3d1d1;
	border-top-width: 1px;
	border-bottom-style: solid;
	
	border-bottom-color:#d3d1d1;
	border-bottom-width: 1px;
	height:90px;
	}
	  
.img_display{
	float:left;
	padding:5px;
	
	}
	.img_text{ padding:10px;
		
		}
		
		.Txt_Dis{
			padding-right:20px;
			}
</style>

	<body id="AAVS_-507-Nexus" lang="en-GB">
		<div class="Basic-Text-Frame">
			<p class="Type-of-Article">&nbsp;</p>
			<p class="Type-of-Article"><span class="CharOverride-1">Research Article</span></p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Title ParaOverride-1">&nbsp;</p>
			<p class="Title ParaOverride-1"><span class="Title">Novel Practical Insight into Application of Platelet-Rich Plasma in Combination with Bioresorbable Silicate 45S5 Bioactive Glass for Bone Defect Repair: an Experimental Study in a Rabbit Model</span></p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Authors ParaOverride-1">&nbsp;</p>
			<p class="Authors ParaOverride-1"><span class="Authors CharOverride-2">Mohamed Tayiser Samy, Ismail Attia Shaban, Islam Foad Mandoh, Ahmed Abdelbaset Ismail El-Azzazy*</span></p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Affiliations ParaOverride-1">Department of Surgery, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, El-Sharkia, Egypt.</p>
		</div>
		<div>
			<p class="Abstract ParaOverride-1">&nbsp;</p>
			<p class="Abstract ParaOverride-1"><span class="CharOverride-3">Abstract</span><span class="CharOverride-4"> | </span><span class="Abstract CharOverride-4">This study was aimed to verify the individual or combining effect of platelet-rich plasma (PRP) and unique biodegradable silicate 45S5 bioactive glass (BG) scaffold on regeneration of metaphyseal tibia defect in a rabbit model. Thirty–six animals were allocated into three groups (n=12 each). In each group, during surgery, right-sided defects were filled with BG, PRP or BG/PRP (1:1), while left-sided defects were served as a control. To visualize and trace defects healing, macroscopic, radiologic and histological examinations were performed at different time points. Bone density/radiopacity and macroscopic (defect size) values were collected and analyzed statistically. Histomorphometric quantitative analysis of H&amp;E stained sections to quantify the percent bone formation at 6 and 8 weeks after implantation was also performed. The gained results showed a significant increase of bone regeneration by 60 days in both BG and BG/PRP–groups (P&lt;0.05 and P&lt;0.001, respectively). Whereas, the healing pattern created by PRP/BG was better comparing to that of BG alone. We noticed unexpectedly incomplete defect closure in PRP-group by 60 days, even though and interestingly, PRP alone accelerated bone radiopacity and new osseous formation significantly only at early stages of healing period (P&lt;0.01). Histomorphometric analyzed data indicated an increasing bone formation over time in all treated defects except PRP during 8 weeks. In conclusion, PRP alone does not provide an appreciated healing effect; however, in future, use of PRP combined with 45S5 BG might be clinically beneficial for proper bone regeneration as safe and appropriate biomaterial.</span></p>
		  <p class="Abstract ParaOverride-1">&nbsp;</p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Editor----Citation"><span class="CharOverride-3">Editor</span> | Kuldeep Dhama, Indian Veterinary Research Institute, Uttar Pradesh, India</p>
			<p class="Editor----Citation"><span class="CharOverride-3">Received</span> | August 18, 2014; <span class="CharOverride-3">Revised</span> | September 02, 2014; <span class="CharOverride-3">Accepted</span> | September 03, 2014; <span class="CharOverride-3">Published</span> | September 14, 2014&#9;&#9;</p>
			<p class="Editor----Citation"><span class="CharOverride-3">*Correspondence</span> | Ahmed Abdelbaset Ismail El-Azzazy, Zagazig University, Egypt; <span class="CharOverride-5">Email</span>: a4ismail@yahoo.co.uk</p>
			<p class="Editor----Citation"><span class="CharOverride-3">Citation </span>| Samy MT, Shaban IA, Mandoh IF, El-Azzazy AAI (2014). Novel practical insight into application of platelet-rich plasma in combination with bioresorbable silicate 45S5 bioactive glass for bone defect repair: an Eexperimental study in a rabbit model. Adv. Anim. Vet. Sci. 2 (8): 424-432.</p>
			<p class="Editor----Citation"><span class="CharOverride-3">DOI </span>| <a href="http://dx.doi.org/10.14737/journal.aavs/2014/2.8.424.432"><span class="Hyperlink">http://dx.doi.org/10.14737/journal.aavs/2014/2.8.424.432</span></a><span class="CharOverride-4"> </span></p>
			<p class="Editor----Citation"><span class="Editor---Citation CharOverride-5" lang="en-US">ISSN </span><span class="Editor---Citation CharOverride-5" lang="en-US">(</span><span class="Editor---Citation CharOverride-5" lang="en-US">Online</span><span class="Editor---Citation CharOverride-5" lang="en-US">)</span> | 2307-8316; <span class="Editor---Citation CharOverride-5" lang="en-US">ISSN </span><span class="Editor---Citation CharOverride-5" lang="en-US">(Print) </span> | 2309-3331 </p>
			<p class="Editor----Citation"><span class="CharOverride-3">Copyright </span>© 2014 El-Azzazy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Heading-1--Introduction----">&nbsp;</p>
		  <p class="Heading-1--Introduction----">INTRODUCTION</p>
		  <p class="Caps-on-First-Para">&nbsp;</p>
			<p class="Caps-on-First-Para"><span class="_idGenDropcap-1">A</span>lthough current surgical strategies; including autogenous grafts or alloplastic materials applied for large bone defect repair are successful in a wide range, however, they have some significant deficiencies. Particularly, limited availability with donor site morbidity in the use of autogenous grafts, and risk of disease transmission, rejection, lack of osteoinductivity and eventual graft lysis in the use of alloplastic materials have been recorded (Fang et al., 2006; Almaiman et al., 2013). At this regards, biomaterials that are safe, strongly incorporate with bone tissue and much osteoinductivity are really essential as a clinical alternative to osseous grafts. Silicate bioactive glass (BG) especially 45S5 particulate (Hench, 1998) is resorbable bioactive synthetic ceramic that has both potentiality to form strong incorporation with osseous tissue and antimicrobial effect (Abdollahi et al., 2013; Rivadeneira et al., 2013). Additionally, it has been shown to lend <span class="Styles-for-Word-RTF-Imported-Lists_Word-Imported-List-Style2 CharOverride-8">g</span><span class="Styles-for-Word-RTF-Imported-Lists_Word-Imported-List-Style2 CharOverride-8">reater </span><span class="Styles-for-Word-RTF-Imported-Lists_Word-Imported-List-Style2 CharOverride-8">and faster bone formation effects, through in vivo studies, when </span><span class="Styles-for-Word-RTF-Imported-Lists_Word-Imported-List-Style2 CharOverride-8">tested with other ceramics in multiple tissues (Wheeler et al., </span><span class="Styles-for-Word-RTF-Imported-Lists_Word-Imported-List-Style2 CharOverride-8">2000; Vogel et al., 2001). Several </span><span class="CharOverride-8">protein- and gene- factors </span><span class="CharOverride-8">required during endogenous bone healing cascade, e.g., transforming growth</span><span class="CharOverride-8"> factor-β, bone morphogenetic proteins and others have been approved</span><span class="CharOverride-8"> to stimulate osteogenesis (Lieberman et al., 2002). Rich source of</span><span class="CharOverride-8"> these factors that could be readily obtained is platelet-rich</span><span class="CharOverride-8"> plasma (PRP) (Wang and Avila, 2007). Since, PRP could be</span><span class="CharOverride-8"> autogenously employed; there is no risk of iatrogenic infection or</span><span class="CharOverride-8"> immune stimulation (Marx et al., 1998; Sanchez et al., 2003</span><span class="CharOverride-8">). However, single (alone) or complementary (with other biomaterial) effect of</span><span class="CharOverride-8"> PRP still needs more clarification especially through in vivo studies</span><span class="CharOverride-8">. For assurance, there have been multiple trials evaluating the effect</span><span class="CharOverride-8"> of PRP merged with BG (not the type used here</span><span class="CharOverride-8">) on human and animals (only with oral and maxillofacial defects</span><span class="CharOverride-8">), nonetheless, this combination remains questionable (Demir et al., 2007; Trindade</span><span class="CharOverride-8">-Suedam et al., 2010; Carvalho et al., 2011; Penteado et</span><span class="CharOverride-8"> al., 2013). Therefore, the main concept of the study </span><span class="CharOverride-8">outlined here was to compare the regenerative potentiality of PRP, </span><span class="CharOverride-8">45S5BG or BG/PRP in treatment of metaphyseal tibia defects </span><span class="CharOverride-8">in a rabbit model.</span></p>
			<p class="Caps-on-First-Para">&nbsp;</p>
		  <p class="Caps-on-First-Para">&nbsp;</p>
			<p class="Heading-1--Introduction----"><span class="CharOverride-9">MATERIALS AND METHODS</span></p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Animals</span></p>
			<p class="Body-Text ParaOverride-1">Thirty–six healthy Babion rabbits of age ranged from 2.5 to 3 months-old and weighing between 2 and 2.5 kilogram were used in this study. The experiment was performed in compliance with guidelines developed by Faculty of Veterinary Medicine, Zagazig University Egypt, for the ethical conduct of care and use of animals. Animals were equally and randomly assigned into three treatment groups (n=12 each) according to type of implant: 1) Silicate 45S5 BG, 2) PRP gel, and 3) PRP/ silicate 45S5 BG group.  Each group was further subdivided into four subgroups (n=3 each) based on the scheduled euthanasia time points. </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Preparation of PRP gel</span> </p>
			<p class="Body-Text ParaOverride-1">In accordance to previously published protocol (Marx et al., 1998), PRP gel preparation was started several minutes before surgery (Figure 1A-C). Eight milliliters of whole venous blood was freshly drawn from each animal via jugular venipuncture. Blood sample was then gently mixed with anticoagulant citrate dextrose (ACD; Sigma, Germany), and centrifuged at 5600 rpm for 10 minutes at room temperature. After centrifugation, three layers were obtained; 1) upper portion (contained platelets poor plasma, PPP), 2) middle portion or “buffy coat” (contained platelets rich plasma, PRP), and 3) lower portion (contained RBCs). To increase harvest of obtained platelets as well as proper separation from RBCs, the upper and middle plasma portions were subjected to second centrifugation step at 2400 rpm for 10 minutes. The supernatant contained PPP was then discarded. For gel formation, approximately 3 ml of PRP (contained platelet concentrate) was mixed with calcium chloride/ bovine thrombin mixture (Sigma, Germany) in a water bath at 37<span class="CharOverride-12">o</span>C.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Fabrication of silicate 45S5 bioactive glass</span><span class="CharOverride-13"> </span></p>
			<p class="Body-Text ParaOverride-1">High-pure SiO<span class="CharOverride-14">2</span>, Na<span class="CharOverride-14">2</span>CO<span class="CharOverride-14">3</span>, CaCO<span class="CharOverride-14">3</span> and P<span class="CharOverride-14">2</span>O<span class="CharOverride-14">5</span> powders were used to fabricate BG scaffold with composition 45SiO<span class="CharOverride-14">2</span>−24.5CaO−24.5Na<span class="CharOverride-14">2</span>O−6P<span class="CharOverride-14">2</span>O<span class="CharOverride-14">5</span> mol%. In brief, powders were weighed, mixed and heat processed in alumina crucibles in an electric furnace for 4hrs at 1400<span class="CharOverride-12">o</span>C with a de-carbonation step (5hrs at 950<span class="CharOverride-12">o</span>C). The melt obtained was occasionally swirled to assure homogeneity and attainment of thermal and chemical equilibrium. Once the heat processing was finished, melted glass was poured and pressed to yield disc like shape samples. The glassy discs were annealed at 500<span class="CharOverride-12">o</span>C and then allowed to cool slowly to obtain glass ceramic scaffold (Figure 1D). </p>
			<p>&nbsp;</p>
			
            <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114034022.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114034022.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114034022.png" target="new">Figure 1: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114034022.png"><span>Preparation steps of PRP gel</a></p>
          </div>


			<p class="Body-Text ParaOverride-1"><span class="CharOverride-17"> </span><span class="CharOverride-18">Preparation steps </span><span class="CharOverride-18">of PRP gel; layers after first (A) and second (B) </span><span class="CharOverride-18">centrifugation and PRP gel formation (C). 45S5 silicate bioactive glass </span><span class="CharOverride-18">discs which used as scaffold materials (D).</span><span class="CharOverride-17"> </span></p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Creating surgical defect and biomaterial implantation </span></p>
			<p class="Body-Text ParaOverride-1">Animals were intramuscularly anesthetized using combination of ketamine hydrochloride (30mg/kg; Ketamine<span class="CharOverride-12">®</span>, Rota Medica, Germany) and xylazine (3mg/kg; Xyla-ject<span class="CharOverride-12">®</span>, Adwia, Egypt). Under complete sterile precautions, a longitudinal skin incision of about 1.5 to 2 cm long was made at 1 cm distal to femorotibial joint and over the medial aspect of both right and left tibias. Under constant irrigation with sterile saline solution, 3.5 mm circular cortical bone defect was created using bone drill with 3.0 mm bone drill bit and followed by 3.5 mm surgical tap.  Afterwards implants were carefully packed into the right defect while left defect served as a control. Muscles, fascia and skin were separately closed in a classical manner. During postoperative period, animals were allowed to recover before returning back to the animal facility and received antibiotic for three consecutive days.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp; </p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Macroscopic </span><span class="CharOverride-11">Examination</span> </p>
			<p class="Body-Text ParaOverride-1">In each group,<span class="CharOverride-13"> </span>animals were euthanized at the scheduled time points and defect size measurement was performed. Representative photomicrographs at each time point per each group were also captured.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">X-ray filming </span></p>
			<p class="Body-Text ParaOverride-1">Radiographic evaluation of all examined groups was performed immediately after surgery as well as at 15, 30, 45 and 60 days post operatively. The settings used were; 40 kV and 300 mA at 0.1 s. The obtained radiographs were scanned to quantify bone densities using ImageJ software (NIH Image, USA) at all scheduled observation time points. </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Histopathologic assessment</span></p>
			<p class="Body-Text ParaOverride-1">Animals (n=3 per group) were euthanized at 45 and 60 days postoperatively. Collected specimens were fixed in 10% neutral buffered formalin and de-calcified. Paraffin embedded samples were then serially sectioned (approximately 100 slices with 6 µm slice thickness per defect), and stained with hematoxylin and eosin (H&amp;E) staining method. Finally, sections were dehydrated then covered with mounting medium and cover slip. Photomicrographs were obtained with inverted light microscope.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Histomorphometric measurements </span></p>
			<p class="Body-Text ParaOverride-1">H&amp;E-stained sections of both treated and untreated osseous defects were used for quantification of percent bone formation (mean±SD) at three standardized locations within the defect versus the total area defect. All these threshold measurements were performed using ImageJ software (NIH Image, USA).</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Statistical analysis</span> </p>
			<p class="Body-Text ParaOverride-1">Statistical analyses were performed using GraphPad Prism-4 software (La Jolla, Ca). The obtained data were expressed as mean±SD. Differences between groups were analyzed using a one-way ANOVA and Tukey test for post-hoc comparisons. The significance levels were defined at P&lt;0.05.</p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">RESULTS</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Macroscopic</span><span class="CharOverride-11"> observation </span></p>
			<p class="Body-Text">Measured<span class="CharOverride-13"> </span>values of approximate defect size in all groups are presented in table 1. BG group showed gradual and significant reducing effect on defect size at each time point (P&lt;0.05) compared with reference defects (Figure 2A, B). Noticeable re-buildup was recorded at 60 day time period (Figure 2A). As well, an irregularity was clearly felt on the area of healed defect. Whereas those of PRP - engrafted group revealed higher significant healing effect only at early <span class="Body-Text ParaOverride-1">periods; i.e. 15 and 30 days post injury than those of un-grafted defects (P&lt;0.01 and P&lt;0.001, respectively) (Figure 3B). Following, the degree of healing was not <span lang="en-US">significant at days 45 and 60 follow-up (Fig. 3A, B). Complete reconstruction of defect at day 60 was not observed. Defects engrafted with BG/PRP showed significant difference in defect closure at day 15 postoperatively (P&lt;0.05) (Fig. 4B). Marked significant decrease of the defect size (P&lt;0.01) by day 30 post injury was displayed as compared with their reference defects. Unlike untreated defects, at 45 and 60 days, the defects healed significantly (P&lt;0.05), and were completely closed by 60 days (Fig. 4B). There were no irregularities on area of healed defects (Fig. 4A).</span></span></p>
		  <p class="Body-Text">&nbsp;</p>
		  <p class="Body-Text">&nbsp;</p>
			
            <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114034228.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114034228.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114034228.png" target="new">Figure 2: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114034228.png"><span>Gross observation of silicate 45S5 BG</a></p>
          </div>
          
		  <p class="Figure--and-Table-Heading ParaOverride-1"> <span class="CharOverride-21">Gross </span><span class="CharOverride-21">observation of silicate 45S5 BG treated defects shows complete re-</span><span class="CharOverride-21">buildup by 60 days with a noticeable callus irregularity (circle) (</span><span class="CharOverride-21">A) with significant decreasing effect on defect size at all-</span><span class="CharOverride-21">time point (B). *P&lt;0.05</span></p>
			<p class="Body-Text">&nbsp;</p>
			<div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114035130.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114035130.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035130.png" target="new">Figure 3: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035130.png"><span>Gross observation of PRP treated defects</a></p>
          </div>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-21">Gross observation of</span><span class="CharOverride-21"> PRP treated defects presents lack of incomplete closure by 60</span><span class="CharOverride-21"> days (A). However, interestingly, marked significant healing effect only at</span><span class="CharOverride-21"> 15 and 30 days post injury was evident (B). **</span><span class="CharOverride-21">P&lt;0.01 and ***P&lt;0.001</span></p><br>
			
          <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114033632.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114033632.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114033632.png" target="new">Figure 4: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114033632.png"><span>Gross observation of silicate 45S5 BG/PRP treated defects</a></p>
          </div>
			<p class="Figure--and-Table-Heading ParaOverride-1"> <span class="CharOverride-21">Gross observation o</span><span class="CharOverride-21">f silicate 45S5 BG/PRP treated defects exhibits complete healing b</span><span class="CharOverride-21">y 60 days with a noticeable smooth callus surface (A) an</span><span class="CharOverride-21">d significant decrease of the defect size at all-time point</span><span class="CharOverride-21">s (B). *P&lt;0.05 and **P&lt;0.01</span></p>
		  <p class="Figure--and-Table-Heading ParaOverride-1">&nbsp;</p>
			
            <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114035734.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114035734.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035734.png" target="new">Figure 5: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035734.png"><span>Radiographic evaluation</a></p>
          </div>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-21">Radiographic</span><span class="CharOverride-21"> evaluation displays complete bony regenerate throughout defects treated with silicate</span><span class="CharOverride-21"> 45S5 BG (A) in addition to significant increase in radiopacity</span><span class="CharOverride-21"> (B). *P&lt;0.05</span></p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
			
            <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114033836.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114033836.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114033836.png" target="new">Figure 6: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114033836.png"><span>Radiographic evaluation reveals incomplete osseous</a></p>
          </div>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-21">Radiographic evaluation reveals incomplete </span><span class="CharOverride-21">osseous healing in both PRP- treated and untreated defects (A) </span><span class="CharOverride-21">with a marked significant increase in radiopacity at 30 days </span><span class="CharOverride-21">post-injury (B). *P&lt;0.05 and **P&lt;0.01</span></p><br>
		  <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114033437.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114033437.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114033437.png" target="new">Figure 7: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114033437.png"><span>Radiographic evaluation shows complete bony regenerate</a></p>
          </div>
		  <p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-21">Radiographic evaluation shows complete bony regenerate throughout defects treated </span><span class="CharOverride-21">with silicate 45S5 BG/PRP (A) in addition to significant </span><span class="CharOverride-21">increase in radiopacity mainly at 45 and 60 days post-</span><span class="CharOverride-21">operative (B). *P&lt;0.05, **P&lt;0.01 and ***P&lt;</span><span class="CharOverride-21">0.001</span></p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114035238.jpg" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114035238.jpg" width="80" height="80"></a>
  <p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035238.jpg" target="new">Figure 8: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035238.jpg"><span>Histological findings of treated and untreated defects</a></p>
        </div>
		  <p class="Figure--and-Table-Heading ParaOverride-1">&nbsp; </p>
		  <p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-21">Histological findings of treated and untreated defects </span><span class="CharOverride-21">after H&amp;E staining. Ungrafted defects shows thin woven bone </span><span class="CharOverride-21">trabeculae (arrow) with wide intertrabecular spaces containing granulation tissue (arrowhead) </span><span class="CharOverride-21">at day 45 (A), and incomplete defect fill (arrow) at </span><span class="CharOverride-21">day 60 (B). Silicate 45S5 BG-treated group displays newly </span><span class="CharOverride-21">formed bone invading defect center at day 45. Bone marrow </span><span class="CharOverride-21">is also observed (arrow) (C). Center is completely filled with </span><span class="CharOverride-21">newly immature woven bone (arrow) at day 60 (D). While </span><span class="CharOverride-21">in PRP-treated group, no much newly formed bone tissue (</span><span class="CharOverride-21">arrow) at day 45 is observed (E). Incomplete fill of </span><span class="CharOverride-21">defect with basophilic mineralized bone (arrow) and remnants of PRP (</span><span class="CharOverride-21">arrow head) are indicated at day 60. (F), whereas in </span><span class="CharOverride-21">silicate 45S5 BG/PRP-treated group, the defect is nearly </span><span class="CharOverride-21">replaced by newly formed osseous tissue containing BG particles (arrow) </span><span class="CharOverride-21">at day 45 (G). Complete fill of the bone defect </span><span class="CharOverride-21">with integrated mature lamellar osteoid tissue is indicated (arrow) at </span><span class="CharOverride-21">day 60 (H). 20x magnifications</span></p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
			
            <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150114035242.png" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150114035242.png" width="80" height="80"></a>
<p class="Txt_Dis" ><span><b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035242.png" target="new">Figure 9: </a></b><a href="http://nexusacademicpublishers.com/uploads/figures/20150114035242.png"><span>Bar graph presenting the percent bones formation</a></p>
          </div>
		  <p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-21">Bar graph presenting </span><span class="CharOverride-21">the percent bones formation as indicated by H&amp;E.  Note </span><span class="CharOverride-21">increasing bone formation over time except in PRP by 8 </span><span class="CharOverride-21">weeks.</span></p>
			<p class="Heading-2--History-in-MM-">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
            <p class="Body-Text ParaOverride-1"><span class="CharOverride-23">Radiographic findings </span></p>
            <p class="Body-Text ParaOverride-1">In order to verify the gross findings, radiographic imaging and quantification of bone density in the areas of defects were done at the same scheduled time points. Table 2 shows the measured bone mineralization density (radiopacity) data in both treated and untreated bone defects. In defects implanted with only BG we found a regular and significant increase in bony regenerate with successful healing of the defect by 60 days after surgery (Figure 5A).</p>
            <p class="Body-Text ParaOverride-1">&nbsp;</p>
            <p class="Body-Text ParaOverride-1">Further, radiopacity (bone density) was increased regularly and significantly at 30, 45 and 60 days (P&lt;0.05) comparably with control defects (Figure 5B). While in group received PRP, the new osseous formation was accelerated robustly at 30 days (P&lt;0.01) (Figure 6B), whereas, by 45 and 60 days, the radiopacity increased moderately when compared to control counterparts (P&lt;0.05) (Figure 6B). Even though, complete defect regeneration was not detected over 60 days healing period (Figure 6A). In third group which received combination of BG and PRP, there was evidence of moderate increasing in the volume of newly formed bone and bone densities at 30 and 45 days post operation (P&lt;0.05 and P&lt;0.01,  respectively) (Figure 7A, B). Additionally, slight differences between BG group and PRP/BG group could be noted at those time points. By 60 days, we noticed marked increase in radiopacity that was higher than those of empty defects (P&lt;0.001) (Figure 7A, B).</p>
            <p class="Heading-2--History-in-MM-">&nbsp;</p>
			<p class="Heading-2--History-in-MM-"><span class="CharOverride-11">Histological results</span><span class="CharOverride-9"> </span></p>
			<p class="Body-Text">Generally here we focused on only three descriptive criteria to describe our histological findings; 1) approximate proportion of intertrabecular spaces (cavitation), 2) amount of the newly formed osseous tissue filling defect, and 3) replacement rates of biomaterial with bone tissues, in addition to quantitative histomorphometric analysis. An increasing of bone formation ratio was found in all treated groups at 6 and 8 weeks by histomorphometric measurements except untreated group and PRP by 8 weeks (table 3 and Figure 9). In un-grafted defects, at 45<span class="CharOverride-12">th </span>day, thin wo<span class="Body-Text ParaOverride-1">ven bone with irregular intertrabecular spaces were noted (Figure 8A). </span></p>
			<p class="Body-Text">&nbsp;</p>
		  <p class="Body-Text">&nbsp;</p>
			<p class="Figure--and-Table-Heading"><span class="CharOverride-5">Table 1:</span> <span class="CharOverride-21">Mean</span><span class="CharOverride-21">±SD values of the approximate defect size of both </span><span class="CharOverride-21">grafted right (R) and ungrafted left (L) surgically created osseous </span><span class="CharOverride-21">defects. DOP: day of operation, PO: post-operation.</span></p>
			<table width="657" height="201" class="Table-Style-1" id="table-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-5" />
					<col class="_idGenTableRowColumn-6" />
				</colgroup>
				<tbody>
					<tr class="_idGenTableRowColumn-7">
						<td colspan="2">
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">Groups</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">Day-0</span></p>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">DOP</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">Day-15</span></p>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">PO</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">Day-30</span></p>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">PO</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">Day-45</span></p>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">PO</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">Day-60</span></p>
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">PO</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td rowspan="2">
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">Silicate-45S5 BG</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">L</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">3.5±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.97±0.27</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.10±0.20</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.97±0.25</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.37±0.15</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">R</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">3.5±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.47±0.15</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">1.50±0.20</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.34±0.15</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.03±0.06</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td rowspan="2">
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">PRP</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">L</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">3.5±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.97±0.25</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.50±0.21</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.67±0.06</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.30±0.10</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-11">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">R</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">3.5±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.04±0.15</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.90±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.63±0.15</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.20±0.10</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td rowspan="2">
							<p class="Basic-Paragraph"><span class="Title CharOverride-25">PRP + Silicate-45S5 BG</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">L</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">3.5±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.95±0.26</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">1.77±0.15</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.73±0.06</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.30±0.11</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-12">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">R</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">3.5±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">2.46±0.14</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.90±0.10</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.50±0.20</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-26">0.00±0.00&#9;</span></p>
						</td>
					</tr>
				</tbody>
			</table>
			<p class="Normal" lang="en-US">&nbsp;</p>
		  <p class="Normal" lang="en-US">&nbsp;</p>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-5">Table</span><span class="CharOverride-5"> 2</span>: <span class="CharOverride-21">Mean±SD values of the bone density/radiopacity </span><span class="CharOverride-21">of both grafted right (R) and ungrafted left (L) surgically </span><span class="CharOverride-21">created osseous defects at different time points. DOP: day of </span><span class="CharOverride-21">operation, PO: post-operation.</span></p>
			<table width="657" height="241" class="Table-Style-1" id="table-2">
				<colgroup>
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-16" />
					<col class="_idGenTableRowColumn-17" />
				</colgroup>
				<tbody>
					<tr class="_idGenTableRowColumn-18">
						<td colspan="2">
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">Groups</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">Day-15</span></p>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">PO</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">Day-30</span></p>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">PO</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">Day-45</span></p>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">PO</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">Day-60</span></p>
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">PO</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td rowspan="2">
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">Silicate-45S5 BG</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">L</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">147.687±3.636</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">158.089±9.023</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">162.507±10.946</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">167.092±10.924</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">R</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">163.692±4.836</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">182.733±4.729</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">187.096±9.303</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">200.205±8.671</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td rowspan="2">
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">PRP</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">L</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">118.489±15.808</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">130.079±8.835</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">147.341±12.25</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">152.335±7.424</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-11">
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">R</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">125.62±10.451</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">165.295±13.326</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">170.663±11.587</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">175.58±20.482</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td rowspan="2">
							<p class="Body-Text ParaOverride-1"><span class="Title CharOverride-5">PRP + Silicate-45S5 BG</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">L</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">115.943±8.206</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">130.274±6.554</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">136.659±4.463</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">137.042±9.05</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-12">
						<td height="59">
							<p class="Body-Text ParaOverride-1"><span class="Title">R</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">133.154±5.702</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">144.952±15.083</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">180.769±6.031</span></p>
						</td>
						<td>
							<p class="Body-Text ParaOverride-1"><span class="Title">225.159±15.806</span></p>
							<p class="Body-Text ParaOverride-1"><span class="Title">&#9;</span></p>
						</td>
					</tr>
				</tbody>
			</table>
			<p class="Normal" lang="en-US">&nbsp;</p>
			<p class="Normal" lang="en-US">&nbsp;</p>
			<p class="Figure--and-Table-Heading ParaOverride-2"><span class="CharOverride-5">Table</span><span class="CharOverride-5"> 3:</span> <span class="CharOverride-21">The percent bone formation (mean±SD) as detected </span><span class="CharOverride-21">by H&amp;E 6 and 8 weeks after. PO: post-operation.</span></p>
			<table width="657" height="118" class="Table-Style-1" id="table-3">
				<colgroup>
					<col class="_idGenTableRowColumn-19" />
					<col class="_idGenTableRowColumn-20" />
					<col class="_idGenTableRowColumn-21" />
				</colgroup>
				<tbody>
					<tr class="_idGenTableRowColumn-22">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-27">Groups</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-27">6 weeks PO</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-27">8 weeks PO</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-27">Control (no graft)</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">45.406</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">11.798</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">58.244</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">17.391</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-22">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-27">Silicate-45S5 BG</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">87.117</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">4.104</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">95.946</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">4.054</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-23">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-27">PRP</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">86.108</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">12.887</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">89.297</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">4.409</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-24">
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-27">PRP + Silicate-45S5 BG</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">77.207</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">22.807</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="Title CharOverride-8">94.189</span><span class="Title CharOverride-8" lang="ar-SA">±</span><span class="Title CharOverride-8">5.7205</span></p>
						</td>
					</tr>
				</tbody>
			</table>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">At 60<span class="CharOverride-12">th</span> day, the center of the defect was incompletely filled with immature woven newly formed bone tissue indicated by presence of small empty cavitation in the central defect core (Figure 8B). In BG group, at 45<span class="CharOverride-12">th</span> day, newly formed bone was noted highly invading the center of the defect. Layers of newly formed bone on the borders of fragmented BG molecules were also found (Figure 8C). At 60<span class="CharOverride-12">th</span> day, fragmented biomaterials were evident and center was even completely filled with newly formed bone, mainly of immature woven bone (Figure 8D). In PRP group, at 45<span class="CharOverride-12">th </span>day, there was no much newly formed bony tissue in the defect (Figure 8E). At 60<span class="CharOverride-12">th</span> day, incomplete defect closure with PRP remnants were identified (Figure 8F). While in BG/PRP group, at 45 day, newly formed bone tissue containing bioactive granules (BG) replaced the cavity without evidence of connective tissue (Figure 8G). At 60<span class="CharOverride-12">th</span> day, the defect was entirely filled with new osteoid tissue of mainly mature lamellar bone. Remodeling of newly formed bone with absence of BG granules was observed (Figure 8H). </p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">DISCUSSION </p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">It has been a great challenge to heal large bone defects properly using clinically appropriate and safe biomaterials. Thus, the present study was designed for the first time to examine the efficacy of silicate 45S5 BG in combination with PRP for the repair of long bone defect. Herein, PRP did not improve to some what extent bone healing by 60 days. However, interestingly, marked significant healing effect of PRP was noted only at early period of the study (i.e., 30 days post injury; P&lt;0.01) than those of un-grafted defects. In parallel, other clinical applications have shown that PRP has a positive effect only at early phase of bone healing (Yilmaz et al., 2013). One explanation for this finding could be attributed to the platelets release growth factors immediately at the area, which work only for a period of 7 to 10 days (Marx et al., 1998). Perhaps for this reason some authors have found a significant result of PRP at the initial periods, with no differences at completion of the repair process (Zechner et al., 2003).</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">In contrary, basic research approves the potentiality of PRP to enhance bone regeneration when used alone (Gandhi et al., 2006). However, others could not confirm enhancement effect of PRP on bone healing when combined with other implants (Mooren et al., 2010). Additionally, more recent published study stated that PRP alone or combined with bovine inorganic bone had not exert any significant effect on bone healing of bone cavities created in dogs mandibles (Bassi and Carvalho, 2011). BG type, namely 45S5 BG, was chosen to be used here since it has much more osteostimulatory effect and osteoconductive properties (Schepers and Ducheyne, 1997). The bioactivity of BG scaffolds is due to their ability to form silica-phosphate-calcium rich surface layer through a series of hydro-reactions when it becomes in contact with body fluid (Hench, 1998). With time, this layer acts as a matrix and plays a valuable role in adhesion and proliferation of osteogenic cells to form new osseous tissue (Marelli et al., 2011). </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">In the present study, silicate BG showed a significant defect reconstruction when compared to control defects over the course of 60 days post-injury, as verified by macroscopic, radiologic and histological examination as well as bone density analysis. These findings are in agreement with previous studies demonstrated that BG has been beneficial to repair periodontal osseous lesions (Nevins et al., 2000) and intra-bony defects (Satyanarayana et al., 2012). These findings could be attributed to BG stimulates bone marrow mesenchymal stem cells to differentiate into osteoblast-like cells with a higher mineralized tissue formation (Bosetti and Cannas, 2005). Furthermore, herein, there was no significant statistical difference between silicate BG and PRP/BG in bone healing after 60 days. Histologically, however, the healing induced by PRP/BG was better than that induced by BG alone, as indicated by formation of more mature osteoid tissue. Consistently, more recent studies have been declared that the use of PRP in association with borate BG improved bone healing compared with BG alone (Zhang et al., 2011). </p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">CONCLUSION</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">PRP alone does not provide marked significant improvement in osseous defect healing at 60 days post-injury. Further studies therefore are required to better define their effect during process of bone repair. However, silicate 45S5 BG improves bone healing particularly when engrafted with PRP. </p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">ACKNOWLEDGEMENTS</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">The authors would like to thank Dr. Hani Kamal; Department of Physics, Faculty of Science, Mansura Uni. for excellent assistance in preparation of BG. Also thanks to Prof. Dr. Mohamed Hammed; Department of Pathology, Faculty of Vet. Med., Zagazig Uni., for his appreciated role in interpretation of the histopathological findings. </p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1"><span class="Heading-1--Introduction----- CharOverride-29">CONFLICTS OF INTEREST</span></p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">The authors indicate no potential conflicts of interest.</p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----"><span class="CharOverride-9">References</span></p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			
			  <li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Abdollahi S, Ma C, Cerruti M (2013</span><span class="CharOverride-19">). Surface transformations of Bioglass 45S5 during scaffold synthesis for bone</span><span class="CharOverride-19"> tissue engineering. Langmuir. 5: 1466-74. </span><a href="http://dx.doi.org/10.1021/la304647r"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1021/la304647r</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Almaiman M, Al-Bargi H, </span><span class="CharOverride-19">Manson P (2013). Complication of anterior iliac bone graft harvesting </span><span class="CharOverride-19">in 372 adult patients from may 2006 to may 2011 </span><span class="CharOverride-19">and a literature review. Craniomaxillofac Trauma Reconstr. 6: 257-66. </span><a href="http://dx.doi.org/10.1055/s-0033-1357510"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1055/s-0033-1357510</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Bassi</span><span class="CharOverride-19"> A, Carvalho P (2011). Repair of bone cavities in dog</span><span class="CharOverride-19">’s mandible filled with inorganic bovine bone and bioactive glass</span><span class="CharOverride-19"> associated with platelet rich plasma. Braz Dent J. 22: 14-20</span><span class="CharOverride-19">.</span></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Bosetti M, Cannas M (2005). The effect of bioactive glasses</span><span class="CharOverride-19"> on bone marrow stromal cells differentiation. Biomaterials. 26: 3873-3879. </span><a href="http://dx.doi.org/10.1016/j.biomaterials.2004.09.059"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1016/j.biomaterials.2004.09.059</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Carvalho</span><span class="CharOverride-19"> M, Suaid F, Santamaria M, Casati M, Nociti F, Sallum</span><span class="CharOverride-19"> A, Sallum E (2011). Platelet-rich plasma plus bioactive glass</span><span class="CharOverride-19"> in the treatment of intra-bony defects: a study in</span><span class="CharOverride-19"> dogs. J Appl Oral Sci. 19: 82-89. </span><a href="http://dx.doi.org/10.1590/S1678-77572011000100016"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1590/S1678-77572011000100016</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Demir B, Sengun</span><span class="CharOverride-19"> D, Berberoglu A (2007). Clinical evaluation of platelet-rich plasma</span><span class="CharOverride-19"> and bioactive glass in the treatment of intra-bony defects</span><span class="CharOverride-19">. J Clin Periodontol. 34: 709-715. </span><a href="http://dx.doi.org/10.1111/j.1600-051X.2007.01108.x"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1111/j.1600-051X.2007.01108.x</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Fang T, Nacamuli R, Song</span><span class="CharOverride-19"> H, Fong K, Shi Y, Longaker M (2006). Guided tissue</span><span class="CharOverride-19"> regeneration enhances bone formation in a rat model of failed</span><span class="CharOverride-19"> osteogenesis. Plast Reconstr Surg. 117: 1177-1185. </span><a href="http://dx.doi.org/10.1097/01.prs.0000204581.59190.53"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1097/01.prs.0000204581.59190.53</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Gandhi A, Doumas C</span><span class="CharOverride-19">, O’Connor J, Parsons J, Lin S (2006). The effects</span><span class="CharOverride-19"> of local platelet rich plasma delivery on diabetic fracture healing</span><span class="CharOverride-19">. Bone. 38: 540-546. </span><a href="http://dx.doi.org/10.1016/j.bone.2005.10.019"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1016/j.bone.2005.10.019</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Hench L (1998). Bioactive materials: the potential</span><span class="CharOverride-19"> for tissue regeneration. J Biomed Mater Res. 41: 511-518. </span><a href="http://dx.doi.org/10.1002/(SICI)1097-4636(19980915)41:4&lt;511::AID-JBM1&gt;3.0.CO;2-F"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1002/(SICI)1097-4636(19980915)41:4&lt;511::AID-JBM1&gt;3.0.CO;2-F</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Lieberman</span><span class="CharOverride-19"> J, Daluiski A, Einhorn T (2002). The role of growth</span><span class="CharOverride-19"> factors in the repair of bone. Biology and clinical applications</span><span class="CharOverride-19">. J Bone Joint Surg Am. 84-A: 1032-1044.</span></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Marelli B</span><span class="CharOverride-19">, Ghezzi C, Mohn D, Stark W, Barralet J, Boccaccini A</span><span class="CharOverride-19">, Nazhat S (2011). Accelerated mineralization of dense collagen-nano bioactive</span><span class="CharOverride-19"> glass hybrid gels increases scaffold stiffness and regulates osteoblastic function</span><span class="CharOverride-19">. Biomaterials. 32: 8915-8926. </span><a href="http://dx.doi.org/10.1016/j.biomaterials.2011.08.016"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1016/j.biomaterials.2011.08.016</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Marx R, Carlson E, Eichstaedt R, Schimmele</span><span class="CharOverride-19"> S, Strauss J, Georgeff K (1998). Platelet-rich plasma: Growth</span><span class="CharOverride-19"> factor enhancement for bone grafts. Oral Surg Oral Med Oral</span><span class="CharOverride-19"> Pathol Oral Radiol Endod. 85: 638-646. </span><a href="http://dx.doi.org/10.1016/S1079-2104(98)90029-4"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1016/S1079-2104(98)90029-4</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Mooren R, Dankers A</span><span class="CharOverride-19">, Merkx M, Bronkhorst E, Jansen J, Stoelinga P (2010). The</span><span class="CharOverride-19"> effect of platelet-rich plasma on early and late bone</span><span class="CharOverride-19"> healing using a mixture of particulate autogenous cancellous bone and</span><span class="CharOverride-19"> Bio-Oss: an experimental study in goats. Int J Oral</span><span class="CharOverride-19"> Maxillofac Surg. 39: 371-378. </span><a href="http://dx.doi.org/10.1016/j.ijom.2009.12.019"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1016/j.ijom.2009.12.019</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Nevins M, Camelo M, Nevins M</span><span class="CharOverride-19">, King C, Oringer R, Schenk R, Fiorellini J (2000). Human</span><span class="CharOverride-19"> histologic evaluation of bioactive ceramic in the treatment of periodontal</span><span class="CharOverride-19"> osseous defects. Int J Periodontics Restorative Dent. 20: 458-467.</span></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Penteado</span><span class="CharOverride-19"> L, Colombo C, Penteado R, Assis A, Gurgel B (2013</span><span class="CharOverride-19">). Evaluation of bioactive glass and platelet-rich plasma for bone</span><span class="CharOverride-19"> healing in rabbit calvarial defects. Journal of Oral Science. 55</span><span class="CharOverride-19">: 225-232. </span><a href="http://dx.doi.org/10.2334/josnusd.55.225"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.2334/josnusd.55.225</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Rivadeneira J, Carina M, Boccaccini R, Gorustovich A (2013</span><span class="CharOverride-19">). In vitro antistaphylococcal effects of a novel 45S5 bioglass/agar</span><span class="CharOverride-19">-gelatin biocomposite films. J Appl Microbiol. 115: 604-12. </span><a href="http://dx.doi.org/10.1111/jam.12254"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1111/jam.12254</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Sanchez </span><span class="CharOverride-19">A, Sheridan P, Kupp L (2003). Is platelet-rich plasma </span><span class="CharOverride-19">the perfect enhancement factor? A current review. Int J Oral </span><span class="CharOverride-19">Maxillofac Implants. 18: 93-103.</span></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Satyanarayana K, Anuradha B, Srikanth G, </span><span class="CharOverride-19">Chandra P, Anupama T, Durga P (2012). Clinical Evaluation of </span><span class="CharOverride-19">Intrabony Defects in Localized Aggressive Periodontitis Patients with and without </span><span class="CharOverride-19">Bioglass- An In-vivo Study. Kathmandu Univ Med J (KUMJ). </span><span class="CharOverride-19">10: 11-15. </span><a href="http://dx.doi.org/10.3126/kumj.v10i1.6906"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.3126/kumj.v10i1.6906</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Schepers E, Ducheyne P (1997). Bioactive glass particles </span><span class="CharOverride-19">of narrow size range for the treatment of oral bone </span><span class="CharOverride-19">defects: a 1-24 month experiment with several materials and particle </span><span class="CharOverride-19">sizes and size ranges. J Oral Rehabil. 24: 171-181. </span><a href="http://dx.doi.org/10.1046/j.1365-2842.1997.00512.x"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1046/j.1365-2842.1997.00512.x</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Trindade-</span><span class="CharOverride-19">Suedam I, de Morais J, Faeda R, Leite F, Tosoni </span><span class="CharOverride-19">G, Neto C, Marcantonio E, Scaf G, (2010). Bioglass associated </span><span class="CharOverride-19">with leukocyte-poor platelet-rich plasma in the rabbit maxillary </span><span class="CharOverride-19">sinus: histomorphometric, densitometric, and fractal analysis. J Oral Implantol. 36: </span><span class="CharOverride-19">333-343. </span><a href="http://dx.doi.org/10.1563/AAID-JOI-D-09-00072"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1563/AAID-JOI-D-09-00072</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Vogel M, Voigt C, Gross U, Muller-Mai C (</span><span class="CharOverride-19">2001). In vivo comparison of bioactive glass particles in rabbits. </span><span class="CharOverride-19">Biomaterials. 22: 357-362. </span><a href="http://dx.doi.org/10.1016/S0142-9612(00)00191-5"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1016/S0142-9612(00)00191-5</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Wang H, Avila G (2007). Platelet rich </span><span class="CharOverride-19">plasma: myth or reality? Eur J Dent. 1: 192-194.</span></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Wheeler </span><span class="CharOverride-19">D, Eschbach E, Hoellrich R, Montfort M, Chamberland D (2000). </span><span class="CharOverride-19">Assessment of resorbable bioactive material for grafting of critical-size </span><span class="CharOverride-19">cancellous defects. J Orthop Res. 18: 140-148. </span><a href="http://dx.doi.org/10.1002/jor.1100180120"><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.1002/jor.1100180120</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Yilmaz S, Karaca </span><span class="CharOverride-19">E, Ipci S, Cakar G, Kuru B, Kullu S, Horwitz </span><span class="CharOverride-19">J (2013). Radiographic and histologic evaluation of platelet-rich plasma </span><span class="CharOverride-19">and bovine-derived xenograft combination in bilateral sinus augmentation procedure. </span><span class="CharOverride-19">Platelets. 24: 308-315. </span><a href="http://dx.doi.org/10.3109/09537104.2012.695033 "><span class="Hyperlink CharOverride-19">http://dx.doi.org/10.3109/09537104.2012.695033</span></a></li>
		  <li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Zechner W, Tangl S, Tepper G, Furst </span><span class="CharOverride-19">G, Bernhart T, Haas R, Mailath G, Watzek G (2003). </span><span class="CharOverride-19">Influence of platelet-rich plasma on osseous healing of dental </span><span class="CharOverride-19">implants: a histologic and histomorphometric study in minipigs. Int J </span><span class="CharOverride-19">Oral Maxillofac Implants. 18: 15-22.</span></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="CharOverride-19">Zhang Y, Wang G, Sun </span><span class="CharOverride-19">Y, Zhang C (2011). Combination of platelet-rich plasma with </span><span class="CharOverride-19">degradable bioactive borate glass for segmental bone defect repair. Acta </span><span class="CharOverride-19">Orthop Belg. 77: 110-115.</span></li>
                <p>&nbsp;</p>
                <p>&nbsp;</p>
                <p>&nbsp;</p>
                <p>&nbsp;</p>
          <p>&nbsp;</p>
		  
		</div>
	</body>
</html>
